The weekly litigation news digest is live. Subscribe now

IP Verse

Axsome Malta competitive analysis

Loading summary...

Latest patents of Axsome Malta opposed by its competitors

Explore Axsome Malta's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 27, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3509582
Dec 20, 2023Solvate Form Of (R)-2-Amino-3-Phenylpropyl Carbamate1
EP3509581
Nov 9, 2022Formulations Of (R1
EP2968208
Jul 20, 2022Treatment Of Cataplexy1

Latest PTAB cases involving Axsome Malta

Discover the latest PTAB cases involving Axsome Malta, highlighting their recent legal challenges and patent disputes.

Last updated on: Dec 1, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Axsome Malta

IPR2024-01418Sep 25, 2024HIKMA PHARMACEUTICALS USAAXSOME MALTATerminated-Settled

Peer Comparison New

IP litigation analysis comparing Axsome Malta with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 27, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AXSOME MALTA - 3 - 1
HIKMA PHARMACEUTICALS USA - - 2 -
KRAUS & LEDERER PARTGMBB68 - - -
SANDOZ1191619 -